About Epithalon Research Epithalon is a synthetic tetrapeptide investigated in published scientific literature involving peptide biology, telomere biology, cellular aging research models, molecular signaling pathways, gene expression studies, and experimental peptide pharmacology
An injectable protocol targeting a specific injury, combined with oral dosing for systemic support, leverages the advantages of both approaches
Oral administration may be considered in research for local gastrointestinal effects or when non-invasive delivery is prioritized, but it generally demonstrates greater variability in exposure and response
It is considered an experimental compound and therefore the decision is made between you and your doctor whether this is the right treatment for you
Macrophage and fibroblast infiltration increase significantly, with measurable improvements in tendon-to-bone healing within 10 to 14 days in animal models